Pre-Open Stock Movers 02/13: (DBD) (LSCC) (GERN) Higher; (AQ) (BABY) (QLYS) Lower (more...)

February 13, 2019 9:29 AM

Today's Pre-Open Movers

Diebold Nixdorf (NYSE: DBD) 35.4% HIGHER; reported Q4 EPS of ($0.08), $0.08 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.22 billion. Diebold Nixdorf sees FY2019 revenue of $4.4-4.5 billion, versus the consensus of $4.54 billion.v

Aquantia Corp (NYSE: AQ) 25.5% LOWER; reported Q4 EPS of ($0.09), $0.10 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $33.55 million.

Natus Medical (NASDAQ: BABY) 19% LOWER; reported Q4 EPS of $0.43, $0.06 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $141 million versus the consensus estimate of $136.65 million. Natus Medical sees Q1 2019 EPS of $0.01-$0.08, versus the consensus of $0.31. Natus Medical sees Q1 2019 revenue of $111-115 million, versus the consensus of $131.3 million. Natus Medical sees FY2019 EPS of $1.12-$1.49, versus the consensus of $1.72. Natus Medical sees FY2019 revenue of $490-510 million, versus the consensus of $541.61 million.

Qualys (NASDAQ: QLYS) 16.5% LOWER; reported Q4 EPS of $0.51, $0.11 better than the analyst estimate of $0.40. Revenue for the quarter came in at $74.2 million versus the consensus estimate of $74.13 million. Qualys sees Q1 2019 EPS of $0.41-$0.43, versus the consensus of $0.42. Qualys sees Q1 2019 revenue of $74.5-75.2 million, versus the consensus of $77.11 million. Qualys sees FY2019 EPS of $1.84-$1.89, versus the consensus of $1.86. Qualys sees FY2019 revenue of $320-323 million, versus the consensus of $331.2 million.

Lattice Semiconductor (NASDAQ: LSCC) 16% HIGHER; reported Q4 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $96 million versus the consensus estimate of $95.1 million. Lattice Semiconductor sees Q1 2019 revenue of $94-98 million, versus the consensus of $93.72 million.

Unisys Corp. (NYSE: UIS) 15% HIGHER; reported Q4 EPS of $0.97, $0.31 better than the analyst estimate of $0.66. Revenue for the quarter came in at $754.6 million versus the consensus estimate of $751.9 million.

Geron Corporation (NASDAQ: GERN) 13% HIGHER; BTIG initiates coverage on with a Buy rating and a price target of $4.00.

Groupon (NASDAQ: GRPN) 11.9% LOWER; reported Q4 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $799.9 million versus the consensus estimate of $788.65 million.

Quotient Technology (NYSE: QUOT) 10.9% LOWER; reported Q4 EPS of ($0.05), $0.12 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $107.1 million versus the consensus estimate of $108.65 million. Quotient Technology sees Q1 2019 revenue of $94-98 million, versus the consensus of $105.42 million.

Cray (NASDAQ: CRAY) 9% LOWER; reported Q4 EPS of ($0.22), $0.20 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $163 million versus the consensus estimate of $157.9 million. Cray sees Q1 2019 revenue of $70 million, versus the consensus of $72.17 million.

OncoCyte Corp (NYSE: OCX) 7.6% HIGHER; Piper Jaffray analyst initiates coverage with a Overweight rating and a price target of $6.00.

Exelixis (NASDAQ: EXEL) 6.1% HIGHER; reported Q4 EPS of $0.37, $0.13 better than the analyst estimate of $0.24. Revenue for the quarter came in at $228.6 million versus the consensus estimate of $188.76 million.

Twilio (NYSE: TWLO) 6% LOWER; reported Q4 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $186.2 million versus the consensus estimate of $185.01 million. Twilio sees Q1 2019 EPS of $0.00-$0.01, versus the consensus of $0.02. Twilio sees Q1 2019 revenue of $212-214 million, versus the consensus of $186.55 million. Twilio sees FY2019 EPS of $0.08-$0.11, versus the consensus of $0.16. Twilio sees FY2019 revenue of $1.028-1.036 billion, versus the consensus of $829.51 million.

Bloom Energy Corp. (NYSE: BE) 5.7% HIGHER; Raymond James upgraded from Market Perform to Outperform with a price target of $13.00.

Cornerstone OnDemand (NASDAQ: CSOD) 5.2% LOWER; reported Q4 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $138.2 million versus the consensus estimate of $129.88 million. Cornerstone OnDemand sees Q1 2019 revenue of $134.5-136.5 million, versus the consensus of $135.9 million. Cornerstone OnDemand sees FY2019 revenue of $558-568 million, versus the consensus of $567 million.

Freeport-McMoRan (NYSE: FCX) 5% HIGHER; Morgan Stanley upgraded from Equalweight to Overweight with a price target of $14.00 (from $16.00).

TripAdvisor (NASDAQ: TRIP) 4.6% LOWER; reported Q4 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $346 million versus the consensus estimate of $342.69 million.

Interpublic Group of Cos. (NYSE: IPG) 4.5% HIGHER; reported Q4 EPS of $0.89, $0.10 better than the analyst estimate of $0.79. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.34 billion.

DISH Network (NASDAQ: DISH) 4.5% LOWER; reported Q4 EPS of $0.64, $0.03 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $3.31 billion versus the consensus estimate of $3.28 billion.

Activision Blizzard (NASDAQ: ATVI) 4.4% HIGHER; reported Q4 EPS of $0.90, $0.38 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $2.38 billion versus the consensus estimate of $3.04 billion. Activision Blizzard sees Q1 2019 EPS of $0.63, versus the consensus of $0.46. Activision Blizzard sees Q1 2019 revenue of $1.715 billion, versus the consensus of $1.46 billion. Activision Blizzard sees FY2019 EPS of $1.85, versus the consensus of $2.58. Activision Blizzard sees FY2019 revenue of $6.025 billion, versus the consensus of $7.3 billion. On its conference call, the company announced a 8% headcount reduction.

Hilton Worldwide (NYSE: HLT) 3.9% HIGHER; reported Q4 EPS of $0.79, $0.10 better than the analyst estimate of $0.69. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.27 billion.

Docusign Inc. (NASDAQ: DOCU) 3% HIGHER; Deutsche Bank upgraded from Hold to Buy with a price target of $65.00 (from $50.00).

Mellanox Technologies (NASDAQ: MLNX) 1.7% HIGHER; Talks between Xilinx (NASDAQ: XLNX) and Mellanox Technologies (NASDAQ: MLNX) broke down last week, according to Globes, citing a separate report from Haaretz. Mellanox founder and CEO Eyal Waldman pushed the asking price for the company up to $6.7 billion.

Intuitive Surgical (NASDAQ: ISRG) 1.4% LOWER; Johnson & Johnson entered into a definitive agreement to acquire Auris Health, Inc. for approximately $3.4 billion in cash

MacroGenics, Inc. (Nasdaq: MGNX) 1.1% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock pursuant to its existing shelf registration statement.

Categories

Special Reports

Next Articles